An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering.
Saved in:
| Title: | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering. |
|---|---|
| Authors: | Cui G; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA., Botuyan MV; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA., Drané P; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hu Q; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA., Bragantini B; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA., Thompson JR; The Hormel Institute, University of Minnesota, Austin, MN, USA., Schuller DJ; Cornell High Energy Synchrotron Source, Cornell University, Ithaca, NY, USA., Detappe A; Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Perfetti MT; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., James LI; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Frye SV; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Chowdhury D; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mer G; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. mer.georges@mayo.edu.; Department of Cancer Biology, Mayo Clinic, Rochester, MN, USA. mer.georges@mayo.edu. |
| Source: | Nature communications [Nat Commun] 2023 Sep 29; Vol. 14 (1), pp. 6091. Date of Electronic Publication: 2023 Sep 29. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37773238 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cui+G%22">Cui G</searchLink>; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Botuyan+MV%22">Botuyan MV</searchLink>; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Drané+P%22">Drané P</searchLink>; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hu+Q%22">Hu Q</searchLink>; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Bragantini+B%22">Bragantini B</searchLink>; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+JR%22">Thompson JR</searchLink>; The Hormel Institute, University of Minnesota, Austin, MN, USA.<br /><searchLink fieldCode="AU" term="%22Schuller+DJ%22">Schuller DJ</searchLink>; Cornell High Energy Synchrotron Source, Cornell University, Ithaca, NY, USA.<br /><searchLink fieldCode="AU" term="%22Detappe+A%22">Detappe A</searchLink>; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Perfetti+MT%22">Perfetti MT</searchLink>; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22James+LI%22">James LI</searchLink>; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Frye+SV%22">Frye SV</searchLink>; Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Chowdhury+D%22">Chowdhury D</searchLink>; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mer+G%22">Mer G</searchLink>; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. mer.georges@mayo.edu.; Department of Cancer Biology, Mayo Clinic, Rochester, MN, USA. mer.georges@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Sep 29; Vol. 14 (1), pp. 6091. <i>Date of Electronic Publication: </i>2023 Sep 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37773238 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-023-41821-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6091 Titles: – TitleFull: An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cui G – PersonEntity: Name: NameFull: Botuyan MV – PersonEntity: Name: NameFull: Drané P – PersonEntity: Name: NameFull: Hu Q – PersonEntity: Name: NameFull: Bragantini B – PersonEntity: Name: NameFull: Thompson JR – PersonEntity: Name: NameFull: Schuller DJ – PersonEntity: Name: NameFull: Detappe A – PersonEntity: Name: NameFull: Perfetti MT – PersonEntity: Name: NameFull: James LI – PersonEntity: Name: NameFull: Frye SV – PersonEntity: Name: NameFull: Chowdhury D – PersonEntity: Name: NameFull: Mer G IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 09 Text: 2023 Sep 29 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |